Editorial Commentary
Reevaluating Bevacizumab:
The Role of VEGF Inhibitors
in Metastatic Breast Cancer
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP®
The author has no potential conflicts to disclose.
J Adv Pract Oncol 2011;2:138-139 |
© 2011 Harborside Press®
For access to the full length article, please
sign in.
